LONDON (Reuters) -British scientific instruments maker Spectris has agreed to a sweetened offer from U.S. private equity firm ...

The sweetened offer comes days after Advent improved its bid for Spectris, prompting the target to withdraw its ...

US private equity group’s offer nudges out rival bidder once again in race to acquire UK scientific instruments maker ...

Macquarie Group Ltd. is set to buy a minority stake in Portuguese hospital operator Luz Saude SA, outbidding rivals CVC ...

The choice filling process begins at 4 pm on August 7 and end on August 8, 2025. The round 2 allotment result will be ...

KKR ups its bid for Spectris to £4.2 billion, overtaking Advent in a fierce takeover race for the UK scientific instruments ...

Private equity giant KKR has trumped rival Advent's takeover bid for British scientific instruments maker Spectris with an ...

The private equity bidding war for precision instrument business Spectris has stepped up a gear after KKR submitted a fresh ...

Henry Schein's Q2 2025 earnings highlight global sales growth, cost-saving initiatives, margin strategies, and leadership transition plans.

KKR has agreed on a recommended increased cash offer for Spectris at an offer value of £41.75 per share. This values the entire issued and to be issued share capital of Spectris at around £4.2 billion ...

Strong demand is fuelling credit markets, but KKR warns the rally won’t last forever. Here’s how they're balancing risk and opportunity.

US tower company Crown Castle has announced the appointment of Christian Hillabrant as its new president and CEO. Hillabrant ...